Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Breskin

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Journal of Clinical Periodontology|December 16, 2016
The subgingival microbiome, systemic inflammation and insulin resistance: The Oral Infections, Glucose Intolerance and Insulin Resistance StudyRyan T Demmer, Alexander Breskin, Michael Rosenbaum, et al.
American Journal of Respiratory and Critical Care Medicine|January 21, 2025
Early versus Delayed Switching from Controlled to Assisted Ventilation: A Target Trial EmulationCarmen A T Reep, Evert-Jan Wils, Lucas M Fleuren, et al.
Epidemiology (Cambridge, Mass.)|April 17, 2024
Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation StudyRosa Sloot, Alexander Breskin, Lisandro D Colantonio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2018
The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency VirusAlexander Breskin, Daniel Westreich, Stephen R Cole, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2019
The Effects of Hepatitis C Treatment Eligibility Criteria on All-cause Mortality Among People With Human Immunodeficiency VirusAlexander Breskin, Daniel Westreich, Christopher B Hurt, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2021
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapiesSara N Levintow, Kate K Orroth, Alexander Breskin, et al.
BMJ Open|June 27, 2025
Background rates of medical events of interest before and during the COVID-19 pandemic: a longitudinal cohort study using claims dataVictor O Popoola, Daniel Keebler, Michelle Skornicki, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Comparing existing and novel methods for estimating etiology-specific diarrheal disease incidence in hybrid surveillance studiesMaria Garcia Quesada, Alexander Breskin, James A Platts-Mills, et al.
International Journal of Epidemiology|March 24, 2021
Corrigendum to: G-computation for policy-relevant effects of interventions on time-to-event outcomesAlexander Breskin, Andrew Edmonds, Stephen R Cole, et al.
Journal of Affective Disorders|December 17, 2020
Depression, antiretroviral therapy initiation, and HIV viral suppression among people who inject drugs in VietnamSara N Levintow, Brian W Pence, Kimberly A Powers, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of Clinical Periodontology|December 16, 2016
The subgingival microbiome, systemic inflammation and insulin resistance: The Oral Infections, Glucose Intolerance and Insulin Resistance StudyRyan T Demmer, Alexander Breskin, Michael Rosenbaum, et al.
American Journal of Respiratory and Critical Care Medicine|January 21, 2025
Early versus Delayed Switching from Controlled to Assisted Ventilation: A Target Trial EmulationCarmen A T Reep, Evert-Jan Wils, Lucas M Fleuren, et al.
Epidemiology (Cambridge, Mass.)|April 17, 2024
Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation StudyRosa Sloot, Alexander Breskin, Lisandro D Colantonio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2018
The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency VirusAlexander Breskin, Daniel Westreich, Stephen R Cole, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2019
The Effects of Hepatitis C Treatment Eligibility Criteria on All-cause Mortality Among People With Human Immunodeficiency VirusAlexander Breskin, Daniel Westreich, Christopher B Hurt, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2021
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapiesSara N Levintow, Kate K Orroth, Alexander Breskin, et al.
BMJ Open|June 27, 2025
Background rates of medical events of interest before and during the COVID-19 pandemic: a longitudinal cohort study using claims dataVictor O Popoola, Daniel Keebler, Michelle Skornicki, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Comparing existing and novel methods for estimating etiology-specific diarrheal disease incidence in hybrid surveillance studiesMaria Garcia Quesada, Alexander Breskin, James A Platts-Mills, et al.
International Journal of Epidemiology|March 24, 2021
Corrigendum to: G-computation for policy-relevant effects of interventions on time-to-event outcomesAlexander Breskin, Andrew Edmonds, Stephen R Cole, et al.
Journal of Affective Disorders|December 17, 2020
Depression, antiretroviral therapy initiation, and HIV viral suppression among people who inject drugs in VietnamSara N Levintow, Brian W Pence, Kimberly A Powers, et al.
Pageof 6